CAD 1.03
(1.98%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 79.85 Million USD | 22.08% |
2022 | 65.41 Million USD | 318.61% |
2021 | 15.62 Million USD | 13.5% |
2020 | 13.76 Million USD | -45.6% |
2019 | 25.3 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 13.99 Million USD | 14.09% |
2024 Q2 | 7.04 Million USD | -49.63% |
2023 FY | 79.85 Million USD | 22.08% |
2023 Q2 | 23.55 Million USD | -4.34% |
2023 Q4 | 12.26 Million USD | -8.68% |
2023 Q3 | 13.43 Million USD | -42.97% |
2023 Q1 | 24.62 Million USD | 7.01% |
2022 FY | 65.41 Million USD | 318.61% |
2022 Q4 | 23.01 Million USD | 71.3% |
2022 Q3 | 13.43 Million USD | -20.44% |
2022 Q2 | 16.88 Million USD | 39.78% |
2022 Q1 | 12.08 Million USD | 86.05% |
2021 Q4 | 6.49 Million USD | 83.4% |
2021 Q1 | 2.47 Million USD | -20.85% |
2021 Q3 | 3.54 Million USD | 13.65% |
2021 FY | 15.62 Million USD | 13.5% |
2021 Q2 | 3.11 Million USD | 25.69% |
2020 Q3 | 2.86 Million USD | -27.56% |
2020 Q2 | 3.96 Million USD | 4.11% |
2020 Q1 | 3.8 Million USD | -20.34% |
2020 FY | 13.76 Million USD | -45.6% |
2020 Q4 | 3.13 Million USD | 9.1% |
2019 Q3 | 6.01 Million USD | 0.0% |
2019 Q4 | 4.77 Million USD | -20.52% |
2019 FY | 25.3 Million USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 254.89 Thousand CAD | -31228.676% |
CanadaBis Capital Inc. | 22.22 Million CAD | -259.346% |
Decibel Cannabis Company Inc. | 115.95 Million CAD | 31.134% |
Delivra Health Brands Inc. | 12.37 Million CAD | -545.141% |
Entourage Health Corp. | 40.71 Million CAD | -96.143% |
Lifeist Wellness Inc. | 21.65 Million CAD | -268.68% |
Cannara Biotech Inc. | 57.26 Million CAD | -39.461% |
Medicure Inc. | 21.69 Million CAD | -268.1% |
PharmaCielo Ltd. | 1.54 Million CAD | -5079.542% |
Rubicon Organics Inc. | 40.11 Million CAD | -99.059% |
BioSyent Inc. | 31.59 Million CAD | -152.785% |
Voyageur Pharmaceuticals Ltd. | - CAD | -Infinity% |